BNET Industries

Bone Care International Inc.

is in the Pharma Industry

Last Fiscal Year Sales:$17.4M
  • Private
  • US
Dow Jones Description

One of the world's leading biotechnology companies, Genzyme is dedicated to making a major positive impact on the lives of people with serious diseases. Founded in 1981, Genzyme has grown from a small start-up to a diversified enterprise with annual revenues exceeding $2 billion and more than 7,000 employees in locations spanning the globe. With many established products and services helping patients in more than 80 countries, Genzyme is a leader in the effort to develop and apply the most advanced technologies in the life sciences. The company's products and services are focused on rare inherited disorders, kidney disease, orthopaedics, cancer, transplant and immune diseases, and diagnostic testing. Genzyme's commitment to innovation continues today with a substantial development program focused on these fields, as well as heart disease and other areas of unmet medical need.

Director
Ed Staiano
Number of Employees 100
Contact Information

1600 Aspen Commons

Middleton, Wisconsin 53562

www.bonecare.co...

1 608 662 7800

NAICS Code Medicinal and Botanical Manufacturing: 325411

News & Analysis

bone care international inc. - All News and Analysis

Decision Makers

Name (plus bio) Position
Ed Staiano Director
Michael D. Casey Director

Board of Directors

Name (plus bio) Position
Herbert J Conrad Board of Directors

Organization Position Status
Bone Care International, Inc. Director Current
911REVIEW.Org Board of Directors Current
Quickfilter Technologies, Inc Co-CEO and Chairman of the Board Current
Motorola, Inc. President Former
Quickfilter Technologies, Inc Board of Directors Former
The University of New Mexico Ph.D In Mechanical Engineering Former
Bucknell University Master's Degrees Former
The University of New Mexico Master's Degrees Former
Bucknell University Bachelor's Former
The University of New Mexico Bachelor's Former

Herbert Conrad is currently Chief Executive Officer of Sapphire Therapeutics. Mr. Conrad was US president of Roche Pharmaceuticals a company he was affiliated with for 33 years. He has served on the Boards of Dura, UroCor, Sicor, GenVec, and Bone Care International. Mr. Conrad is currently on the Boards of Savient Pharmaceuticals, Celldex Therapeutics, and Symphony Evolution. Mr. Conrad earned his undergraduate and graduate degrees in Pharmacy from the Brooklyn College of Pharmacy. He also has received a Doctorate in Humane Letters (Honorary) from Long Island University.

Organization Position Status
Celldex Therapeutics, Inc. Chief Executive Officer, Sapphire Therapeutics Current
Sapphire Therapeutics, Inc Chairman Current
Pharmasset, Inc. Board of Directors Current
Symphony Evolution Board of Directors Current
Savient Pharmaceuticals, Inc. Board of Directors Current
Sicor, Inc. Board of Directors Current
GenVec, Inc. Board of Directors Current
Celldex Therapeutics, Inc. Board of Directors Current
Bone Care International, Inc. Board of Directors Current
Sapphire Therapeutics, Inc President and Chief Executive Officer Former
Hoffmann-La Roche Inc. President Former
Reliant Pharmaceuticals, Inc. Co-Founder Former
Celldex Therapeutics, Inc. Director of Avant Former
GenVec, Inc. Chairman of the Board of Directors Former
Long Island University Doctorate In Humane Letters Former
Long Island University B.S. Former

Organization Position Status
DURECT Corporation Director, Chairman of the Nominating and Governance Committee Current
Allos Therapeutics, Inc. Pharmaceutical Industry Consultant Current
DURECT Corporation Director Current
Cholestech Corporation Director Current
Lead Discovery Board of Directors Current
AVI BioPharma, Inc. Director Current
Bone Care International, Inc. Director Current
Celgene Corporation Board of Directors Current
Inex Pharmaceuticals Corporation Director Current
Orthologic Corporation Director Current
Allos Therapeutics, Inc. Director Current
Multiple Myeloma Committee Member Current
Pharmion Corporation Committee Member Current
Rare Diseases Clinical Research Network Committee Member Current
Genetic Therapy, Inc. President Former
Genetic Therapy, Inc. Chief Operating Officer Former
Ortho Pharmaceutical Corporation Vice President, Sales and Marketing Former
Johnson & Johnson Vice President of Sales and Marketing Former